Find research datasets worth reusing

Fig. 4 in Bisabolane-type sesquiterpenes from Vernonia amygdalina: Absolute configuration and anti-inflammatory activity

Fig. 4. Relative configuration analysis of the C6–C7 segment in 1, 3, 5 and 7 by Newman projection.

Fig. 3 in Cassane-type diterpenes from roots of Pterolobium macropterum and their anti-inflammatory activity

Fig. 3. Key NOESY correlations of 1 3 and 7–8.

Fig. 4 in Cassane-type diterpenes from roots of Pterolobium macropterum and their anti-inflammatory activity

Fig. 4. Experimental and calculated CD spectra for 4–5 and 7.

Fig. 6 in Chemical constituents of Entandrophragma angolense and their anti-inflammatory activity

Fig. 6. Plausible biogenetic pathway of 3,4-seco-tirucallanes (1–4) in E. angolense.

Fig. 2 in Cassane-type diterpenes from roots of Pterolobium macropterum and their anti-inflammatory activity

Fig. 2. COSY and selected HMBC (1H → 13C) correlations of 1–8.

Fig. 4 in Chlomultiols A-L, sesquiterpenoids from Chloranthus multistachys and their anti-inflammatory activities

Fig. 4. Experimental CD spectra of compounds 8a and 8b.

Fig. 4. Experimental and calculated ECD spectra for 1 and 10 in Chemical constituents of Entandrophragma angolense and their anti-inflammatory activity

Fig. 4. Experimental and calculated ECD spectra for 1 and 10.

Fig. 1 in Chlomultiols A-L, sesquiterpenoids from Chloranthus multistachys and their anti-inflammatory activities

Fig. 1. Chemical structures of compounds 1–15.

Fig. 3 in Chlomultiols A-L, sesquiterpenoids from Chloranthus multistachys and their anti-inflammatory activities

Fig. 3. ORTEP drawings of compounds 1–12 (Thermal ellipsoids 50% probability levers).

Fig. 1 in Cassane-type diterpenes from roots of Pterolobium macropterum and their anti-inflammatory activity

Fig. 1. Isolated compounds (1–10) from the roots extract of P. macropterum.

Fig. 2. 1H–1H COSY and selective HMBC correlations for 1, 3 in Chemical constituents of Entandrophragma angolense and their anti-inflammatory activity

Fig. 2. 1H–1H COSY and selective HMBC correlations for 1, 3/4, 10, and 13.

Fig. 4 in Hyjapones A D, trimethylated acyphloroglucinol meroterpenoids from Hypericum japonicum thunb. With anti-inflammatory activity

Fig. 4. Experimental and calculated ECD spectra of 1–3, 5a and 5b.

Fig. 3. Key 2D in Hyjapones A D, trimethylated acyphloroglucinol meroterpenoids from Hypericum japonicum thunb. With anti-inflammatory activity

Fig. 3. Key 2D correlations of 2.

Fig. 2 in Hyjapones A D, trimethylated acyphloroglucinol meroterpenoids from Hypericum japonicum thunb. With anti-inflammatory activity

Fig. 2. Key HMBC and ROESY correlations of 1.

Fig. 1 in Hyjapones A D, trimethylated acyphloroglucinol meroterpenoids from Hypericum japonicum thunb. With anti-inflammatory activity

Fig. 1. Structures of compounds 1–11.

Fig. 1 in Lanostane triterpenoids from the fruiting bodies of Fomitopsis pinicola and their anti-inflammatory activities

Fig. 1. The structures of compounds 1–13.

Fig. 3. X in Lanostane triterpenoids from the fruiting bodies of Fomitopsis pinicola and their anti-inflammatory activities

Fig. 3. X-ray crystal structure of 1.

Fig. 2. 1H – 1H in Meroterpenoids from the fungus Penicillium sclerotiorum GZU-XW03-2 and their anti-inflammatory activity

Fig. 2. 1H – 1H COSY and key HMBC correlations of compounds 1–7.

Fig. 1 in Meroterpenoids from the fungus Penicillium sclerotiorum GZU-XW03-2 and their anti-inflammatory activity

Fig. 1. Structures of compounds 1–7.

Fig. 4 in Meroterpenoids from the fungus Penicillium sclerotiorum GZU-XW03-2 and their anti-inflammatory activity

Fig. 4. The experimental and calculated ECD spectra of compounds 1–7.